Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eustratios Bananis

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Comparative Effectiveness Research|February 25, 2021
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancerHope S Rugo, Anja Haltner, Lin Zhan, et al.
Molecular Biology of the Cell|June 8, 2004
Microtubule-dependent movement of late endocytic vesicles in vitro: requirements for Dynein and KinesinEustratios Bananis, Sangeeta Nath, Kristie Gordon, et al.
Annals of the Rheumatic Diseases|August 22, 2014
How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?Roy Fleischmann, Désirée van der Heijde, Andrew S Koenig, et al.
Journal of the American Academy of Dermatology|June 30, 2014
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinicsPhilip J Mease, Dafna D Gladman, Philip Helliwell, et al.
Molecular Biology of the Cell|March 16, 2007
Kif5B and Kifc1 interact and are required for motility and fission of early endocytic vesicles in mouse liverSangeeta Nath, Eustratios Bananis, Souvik Sarkar, et al.
Journal of Breast Cancer|February 26, 2021
Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerJee Hyun Kim, Seock Ah Im, Sung Hoon Sim, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET studyPaul Emery, Tore K Kvien, Bernard Combe, et al.
Clinical Rheumatology|April 16, 2018
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trialsVibeke Strand, Eun Bong Lee, Yusuf Yazici, et al.
Annals of the Rheumatic Diseases|August 16, 2015
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugsChristina Charles-Schoeman, Gerd Burmester, Peter Nash, et al.
Rheumatology and Therapy|February 9, 2018
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc AnalysisRoy Fleischmann, Jürgen Wollenhaupt, Stanley Cohen, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Comparative Effectiveness Research|February 25, 2021
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancerHope S Rugo, Anja Haltner, Lin Zhan, et al.
Molecular Biology of the Cell|June 8, 2004
Microtubule-dependent movement of late endocytic vesicles in vitro: requirements for Dynein and KinesinEustratios Bananis, Sangeeta Nath, Kristie Gordon, et al.
Annals of the Rheumatic Diseases|August 22, 2014
How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?Roy Fleischmann, Désirée van der Heijde, Andrew S Koenig, et al.
Journal of the American Academy of Dermatology|June 30, 2014
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinicsPhilip J Mease, Dafna D Gladman, Philip Helliwell, et al.
Molecular Biology of the Cell|March 16, 2007
Kif5B and Kifc1 interact and are required for motility and fission of early endocytic vesicles in mouse liverSangeeta Nath, Eustratios Bananis, Souvik Sarkar, et al.
Journal of Breast Cancer|February 26, 2021
Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerJee Hyun Kim, Seock Ah Im, Sung Hoon Sim, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET studyPaul Emery, Tore K Kvien, Bernard Combe, et al.
Clinical Rheumatology|April 16, 2018
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trialsVibeke Strand, Eun Bong Lee, Yusuf Yazici, et al.
Annals of the Rheumatic Diseases|August 16, 2015
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugsChristina Charles-Schoeman, Gerd Burmester, Peter Nash, et al.
Rheumatology and Therapy|February 9, 2018
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc AnalysisRoy Fleischmann, Jürgen Wollenhaupt, Stanley Cohen, et al.
Pageof 5